University of Tasmania
Browse

File(s) not publicly available

Highly Active Antiretroviral Therapy: Pharmacoeconomic issues in the management of HIV infection

journal contribution
posted on 2023-05-17, 09:29 authored by Sendi, P, Andrew PalmerAndrew Palmer, Gafni, A, Battegay, M
The advent of highly active antiretroviral therapy (HAART), including protease inhibitors and/or non-nucleoside reverse transcriptase inhibitors, for the treatment of HIV infection has led to a dramatic decline of morbidity and mortality. The acquisition costs of HAART are substantial. However, these costs are partially offset by reduced inpatient care for opportunistic infections and other AIDS-related diseases. Furthermore, job productivity in patients infected with HIV is increased under HAART. In developed countries with a low unemployment rate, the discounted value of savings caused by increased productivity in earlier years exceeds the discounted value of later increases in costs resulting from morbidity. Therefore, HAART represents a very efficient treatment strategy that leads to overall cost savings when taking a societal perspective.

History

Publication title

Pharmacoeconomics

Volume

19

Issue

7

Pagination

709-713

ISSN

1170-7690

Department/School

Menzies Institute for Medical Research

Publisher

Adis International Ltd

Place of publication

41 Centorian Dr, Private Bag 65901, Mairangi Bay, Auckland, New Zealand, 10

Repository Status

  • Restricted

Socio-economic Objectives

Evaluation of health and support services not elsewhere classified

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC